MECO DIAGNOSTICS TO PRESENT AT SEED SHOWCASE™ 2023
San Diego, CA – MeCo Diagnostics has announced that it is presenting at Seed Showcase™ as part of Biotech Showcase™ 2023. This year, registered attendees…
Click Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics Programs
NEW YORK – December 23, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today shared multiple accomplishments and…
Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
December 19, 2022 08:00 AM Eastern Standard Time INGELHEIM, Germany & NEW YORK--(BUSINESS WIRE)--Boehringer Ingelheim and Click Therapeutics today announced the launch of an expanded…
Click Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Episodic Migraine
NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has received Breakthrough Device Designation from…
Click Therapeutics Announces Collaboration with the Massachusetts Medical Society to Enable Advancement in Medical Innovation
NEW YORK – December 6, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced their partnership with…
Click Therapeutics Announces Participation in Upcoming Investor Conferences in November and December
NEW YORK – November 11, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that company management…
MECO DIAGNOSTICS ACCEPTED INTO EVONEXUS
San Diego, CA – On October 11th, 2022, EvoNexus, California’s leading non-profit tech incubator, selected MeCo Diagnostics to join its exclusive portfolio of innovative seed-stage…
Click Therapeutics Announces Participation in Upcoming Investor Conferences
NEW YORK – September 14, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky,…
Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
NEW YORK – August 5, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky,…
Click Therapeutics to Present at the H.C. Wainwright 1st Annual Mental Health Conference
NEW YORK – June 23, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky,…